Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors

NEWARK, Calif., Dec. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today announced the appointment of Sarah Noonberg, M.D., Ph.D., Chief Medical Officer of Prothena Corporation plc, to the Protagonist ... Biopharmaceuticals, Gastroenterology, Personnel Protagonist Therapeutics, inflammatory bowel disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news